# FDA Inspection 1272740 - Merck & Cie - March 29, 2023

Source: https://www.keypedia.com/records/fda_inspections/merck-cie/75f8f1e7-ff77-46a3-8686-78371f77e3bc
Source feed: FDA_Inspections

> FDA Inspection 1272740 for Merck & Cie on March 29, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1272740
- Company Name: Merck & Cie
- Inspection Date: 2023-03-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1073579 - 2018-11-02](https://www.keypedia.com/records/fda_inspections/merck-cie/0c3a2443-38dd-4555-af52-48b43a4509df)
- [FDA Inspection 901105 - 2014-02-14](https://www.keypedia.com/records/fda_inspections/merck-cie/27ccc89f-d2ff-464f-8eb3-1aa34779d333)
- [FDA Inspection 659865 - 2010-03-25](https://www.keypedia.com/records/fda_inspections/merck-cie/74d2797f-1ffb-419c-817c-284bf098e5e5)

Company: https://www.keypedia.com/companies/merck-cie/7a318238-e1c9-4962-94fe-53359569a739

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c